Adjustable surgical guide and method of treating vertebral members
    5.
    发明授权
    Adjustable surgical guide and method of treating vertebral members 失效
    可调外科指南及治疗脊椎成员的方法

    公开(公告)号:US06755839B2

    公开(公告)日:2004-06-29

    申请号:US10175221

    申请日:2002-06-19

    IPC分类号: A61B1756

    摘要: A guide and method of using the guide for positioning within a patient between vertebral members for contouring each of the members. The guide comprises a first section and a second section. A first edge is positioned along an edge of the first section, and a second edge is positioned along an edge of the second section. One or more elongated rods extend through the sections. One or both of the sections are movable along the rods to adjust a spacing between the first edge and the second edge. When positioned within the patient, the first edge is aligned along a first vertebral member and the second edge is aligned along a second vertebral manner. A manner of locking the sections is included for preventing the sections from moving relative to each other once the first and second edges are aligned within the patient.

    摘要翻译: 一种使用该引导件在椎体构件之间定位患者之间以用于轮廓化每个构件的引导和方法。 引导件包括第一部分和第二部分。 第一边缘沿着第一部分的边缘定位,并且第二边缘沿着第二部分的边缘定位。 一个或多个细长的杆延伸穿过这些部分。 这些部分中的一个或两个可沿杆移动以调节第一边缘和第二边缘之间的间隔。 当定位在患者体内时,第一边缘沿着第一椎骨构件对准,并且第二边缘沿着第二椎体方式对齐。 包括锁定部分的方式,一旦第一和第二边缘在患者体内对准,就防止这些部分相对于彼此移动。

    IMIDAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
    7.
    发明申请
    IMIDAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY 有权
    调节HSP90活性的咪唑化合物

    公开(公告)号:US20140094436A1

    公开(公告)日:2014-04-03

    申请号:US14103420

    申请日:2013-12-11

    摘要: Compounds of formula (I), pharmaceutical compositions comprising compounds of formula (I) and methods of inhibiting Hsp90 in a cell, treating or preventing a proliferation disorder in a mammal and treating cancer in a mammal comprising administering a compound of formula (I) to a patient or a cell. Variable R5 is an optionally substituted heteroaryl; an optionally substituted 6 to 14-membered aryl; a bicyclic 9-member heterocycle optionally substituted at any substitutable nitrogen or carbon atoms; or a substituent R18, defined herein. Ring A is an aryl or a heteroaryl optionally further substituted with one or more substituents in addition to R3. Substituent R3 is defined herein.

    摘要翻译: 式(I)化合物,包含式(I)化合物的药物组合物和抑制细胞中Hsp90的方法,治疗或预防哺乳动物中的增殖病症并治疗哺乳动物的癌症,其包括给予式(I)化合物至 患者或细胞。 变量R5是任选取代的杂芳基; 任选取代的6至14元芳基; 任选在任何可取代的氮或碳原子上取代的双环9元杂环; 或本文定义的取代基R18。 环A是除了R3之外任选进一步被一个或多个取代基取代的芳基或杂芳基。 取代基R 3在本文中定义。